SCHEMBL1636770

SCHEMBL1636770

Cc1[c]c(C)nc(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3838128 0.74
SCHEMBL2079195 0.74
SCHEMBL16390906 0.74
SCHEMBL16881090 0.74
SCHEMBL3831724 0.74
SCHEMBL3834723 0.74
SCHEMBL1679913 0.74
SCHEMBL7265308 0.74
SCHEMBL1638202 0.70 MEN1 (0.42)
SCHEMBL5946631 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235792-A1 Serine protease inhibitors compromising a hydrogen-bond acceptor TRIGEN LIMITED (GB) 2004-11-25 US claimed
WO-2002057273-A9 SERINE PROTEASE INHIBITORS COMPRISING A HYDROGEN-BOND ACCEPTOR TRIGEN LTD (GB) 2002-11-28 WO claimed
WO-2002057273-A1 SERINE PROTEASE INHIBITORS COMPRISING A HYDROGEN-BOND ACCEPTOR TRIGEN LIMITED (GB) 2002-07-25 WO claimed
JP-2668163-B2 1997-10-27 JP claimed
US-5565472-A 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents PFIZER INC. (US) 1996-10-15 US claimed
EP-0623112-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1994-11-09 EP claimed
WO-1993015058-A1 4-ARYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXO-QUINOLINE DERIVATIVES AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS PFIZER INC. (US) 1993-08-05 WO claimed
EP-0251049-B1 PHOTOPOLYMERISABLE REGISTRATION MATERIALS, PHOTORESIST LAYERS AND LITHOGRAPHIC PRINTING PLATES BASED ON THESE REGISTRATION MATERIALS BASF Aktiengesellschaft (DE) 1992-09-09 EP claimed
EP-0062839-B1 ACYLPHOSPHINE COMPOUNDS AND THEIR USE BASF Aktiengesellschaft (DE) 1984-11-21 EP claimed
EP-0047902-B1 ACYLPHOSPHINESULFIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE BASF Aktiengesellschaft (DE) 1984-11-07 EP claimed
EP-0057474-B1 ACYLPHOSPHINE OXDE COMPOUNDS, THEIR PREPARATION AND USE BASF Aktiengesellschaft (DE) 1984-10-17 EP claimed
US-4428935-A BETA-LACTAMASE INHIBITORS PFIZER INC. (US) 1984-01-31 US claimed
EP-0047902-A2 Acylphosphinesulfide compounds, process for their preparation and their use BASF Aktiengesellschaft (DE) 1982-03-24 EP claimed
US-4298738-A PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COATINGS AND IMKS BASF AKTIENGESELLSCHAFT (DE) 1981-11-03 US claimed
CN-103930423-A Pyrazoloquinoline Derivatives EISAI R&D MAN CO LTD 2014-07-16 CN disclosed
US-8466177-B2 Treating and preventing viral infections THE UAB RESEARCH FOUNDATION (US) 2013-06-18 US disclosed
US-8455511-B2 Pyrrolopyridine derivatives substituted with cyclic amino group TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-06-04 US disclosed
US-4199580-A HYPOTENSIVE AGENTS AND ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1980-04-22 US disclosed
US-4134983-A HYPOTENSIVE, ADRENERGIC BLOCKING AGENTS MERCK & CO., INC. (US) 1979-01-16 US disclosed
US-3969363-A CARDIOVASCULAR DISORDERS CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) 1976-07-13 US disclosed